A Phase III, Multi-center, Randomized, Single-blind (to Evaluator), Parallel, and Positive-controlled Clinical Trial Evaluating the Efficacy and Safety of OPC-1085EL Ophthalmic Solution in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects
Latest Information Update: 31 Mar 2025
At a glance
- Drugs Carteolol/latanoprost (Primary) ; Latanoprost
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Registrational; Therapeutic Use
- Sponsors Otsuka Beijing Research Institute
Most Recent Events
- 27 Mar 2025 Status changed from recruiting to completed.
- 21 Oct 2022 New trial record